Ignyte Acquisition Corp

PINK:PKBO USA Biotechnology
Market Cap
$520.31K
Market Cap Rank
#39181 Global
#12765 in USA
Share Price
$0.02
Change (1 day)
+0.00%
52-Week Range
$0.02 - $0.02
All Time High
$13.05
About

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with cancer, inflammatory, and rare diseases in the United States. The company's lead product candidate is PHP-303, which is in Phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an… Read more

Ignyte Acquisition Corp (PKBO) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2024: 0.113x

Based on the latest financial reports, Ignyte Acquisition Corp (PKBO) has a cash flow conversion efficiency ratio of 0.113x as of September 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.37 Million) by net assets ($-20.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ignyte Acquisition Corp - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Ignyte Acquisition Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Ignyte Acquisition Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ignyte Acquisition Corp ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Ignyte Acquisition Corp (2020–2023)

The table below shows the annual cash flow conversion efficiency of Ignyte Acquisition Corp from 2020 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 $-18.16 Million $-4.76 Million 0.262x -71.66%
2022-12-31 $-8.09 Million $-7.49 Million 0.925x -79.81%
2021-12-31 $-1.94 Million $-8.86 Million 4.580x +2378.78%
2020-12-31 $10.14K $-2.04K -0.201x --